
Sign up to save your podcasts
Or


In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles:
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289)
Speakers:
By Dr. Cush4.7
121121 ratings
In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles:
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289)
Speakers:

701 Listeners

504 Listeners

264 Listeners

3,374 Listeners

1,150 Listeners

122 Listeners

120 Listeners

194 Listeners

518 Listeners

367 Listeners

68 Listeners

5 Listeners

183 Listeners

19 Listeners

6 Listeners